The Association of South-East Asian Nations is to introduce a Common Effective Preferential Tariffs scheme, which it is hoped will lead to tariffs on pharmaceuticals and other products being almost totally abolished within the next 15 years, reports the Bernama news agency of Malaysia.
Under the CEPT scheme, countries which currently charge tariffs of above 20% will have to reduce them to below that figure within five to eight years, while countries which currently charge tariffs of below 20% will have to reduce them to 0%-5% over the same period. It is hoped that tariffs of 0%-5% on imports of pharmaceuticals will be charged within the next 15 years among ASEAN member states.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze